Activist 13D/13G Filings - Affinity Asset Advisors LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-11-13
4:06 pm
Purchase		13GNEXTCURE INC
NXTC		Affinity Asset Advisors LLC2,302,598
8.220%		629,759increase
(+37.65%)		View
2024-08-14
4:05 pm
Purchase		13GClimb Bio Inc.
CLYM		Affinity Asset Advisors LLC1,813,193
2.700%		143,193increase
(+8.57%)		View
2024-06-27
4:47 pm
Purchase		13GNEXTCURE INC
NXTC		Affinity Asset Advisors LLC1,672,839
5.980%		1,672,839increase
(New Position)		View
2024-05-07
6:01 pm
Purchase		13GClimb Bio Inc.
CLYM		Affinity Asset Advisors LLC1,670,000
6.020%		1,670,000increase
(New Position)		View
2024-02-13
4:55 pm
Sale		13GVINCERX PHARMA, INC
VINC		Affinity Asset Advisors LLC0
0.000%		-1,492,771decrease
(Position Closed)		View
2024-02-13
4:48 pm
Purchase		13GSpyre Therapeutics Inc.
SYRE		Affinity Asset Advisors LLC653,409
1.810%		653,409increase
(New Position)		View
2024-02-13
4:45 pm
Sale		13GCONTEXT THERAPEUTICS INC
CNTX		Affinity Asset Advisors LLC328,817
2.060%		-554,837decrease
(-62.79%)		View
2023-07-03
4:20 pm
Purchase		13GSpyre Therapeutics Inc.
SYRE		Affinity Asset Advisors LLC7,477,000
9.230%		7,477,000increase
(New Position)		View
2023-02-13
4:11 pm
Purchase		13GVINCERX PHARMA, INC
VINC		Affinity Asset Advisors LLC1,492,771
7.040%		357,406increase
(+31.48%)		View
2022-05-09
5:11 pm
Purchase		13GCONTEXT THERAPEUTICS INC
CNTX		Affinity Asset Advisors LLC883,654
5.530%		883,654increase
(New Position)		View
2022-02-11
4:13 pm
Purchase		13GVINCERX PHARMA, INC
VINC		Affinity Asset Advisors LLC1,135,365
5.390%		59,145increase
(+5.50%)		View
2021-11-22
2:50 pm
Purchase		13GVINCERX PHARMA, INC
VINC		Affinity Asset Advisors LLC1,076,220
5.120%		1,076,220increase
(New Position)		View